Rapid drug abuse test D005

for ecstasyurineimmunochromatographic

In response to the growing problem of drug abuse, rapid testing reagents can help medical institutions, analysis laboratories, military, police departments and traffic control divisions to conduct drug screening instantly. The Firstep Drug Screen Test is an immunochromatographic reagent for detection of specified parent drugs or their metabolites in urine specimens. In order to provide customers a wide range of options, Firstep Drug Screen Test can be offered in various formats as single-parameter test or combined to multiple-parameter test. Format Single-parameter Cassette Multiple-parameter Dipcard, including 2 in 1, 5 in 1, 7 in 1 test Multiple-parameter Cassette, including 2 in 1, 3 in 1, 4 in 1, 5 in 1 test Product Features • Short processing time • Customized combinations of drug parameters • High sensitivity, specificity and accuracy Scope of application Suspected drug users Ecstasy, 3,4-methylenedioxy methamphetamine is classified as both a stimulant and a hallucinogen. Like methamphetamine, adverse effects of 3,4-methylenedioxy methamphetamine use include jaw clenching, teeth grinding, dilated pupils, perspiring, anxiety, blurred vision, vomiting, and increased blood pressure and heart rate. Overdose of 3,4-methylenedioxy methamphetamine may cause heart failure or extreme heart stroke. 3,4-methylenedioxy methamphetamine is taken orally in tablets or capsules and excreted in urine as parent compound as well as metabolic.